TrialVeterinary dermatology2013

A blinded, randomized, placebo-controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel®) in client-owned dogs with atopic dermatitis.

Sallie B Cosgrove et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.